hours in man2 and dogs.3 Certain patients with advanced congestive heart failure or renal or hepatic disease may exhibit impaired renal excretion.2 The volume of distribution of the compound is similar to that of mannitol3 (extracellular fluid). In nephrectomized dogs, some 40 per cent of an intravenous dose is excreted in the bile and another 10 per cent into the intestine. 4 Normally, the compound is excreted rapidly by the kidney, largely by a process of tubular secretion, so that 90 per cent of an intravenous dose of 0.5 Gm. appears in the urine in 2 hours.2 Chlorothiazide is cleared from the renal eirculationi three and one-half times as fast as creatinine (used for the measurement of glomerular filtration rate), and it can be cleared by the kidney at a rate approaching that of the renal plasma flow (para-aminohippurate clearance).3 Beyer3 noted that chlorothiazide competes with probenecid for renal tubular transport. The rate of tubular secretion of chlorothiazide can be reduced by probenecid without reducing its diuretic properties.
Effect on the Renal Excretion of Electrolytes and Water
Chlorothiazide increases the renal excretion of sodium, potassium, ehloride, and bicarbonate ions.1 3 5 The main action of the compound is to inhibit tubular reabsorptive mechanisms, for the observed effects on electrolyte excretion can be shown to occur in the presenee of a decreased glomerular filtration rate.5 In vitro, chlorothiazide inhibits carbonic anhydrase, a property that led to its discovery. 6 Chlorothiazide produces all average fall in glomerular filtration rate of 20 per cent when given intravenously to normnal subjects.5 The effect appears before any appreciable salt and water depletioln occurs, and is not associated with a change in arterial blood pressure. The depression of glonmerular filtration rate persists iii both hypertensive6 and normal17 subjects imaintained for periods of from 4 days to several weeks on chlorothiazide, although in such instances fluid amid electrolyte depletion beconie contributing faetors. Crosley Figure 2 The structural formulae of some saliuretic sulfonamide compounds are presented. At the top is the parent compound, sulfanilamide, which, in addition to its antimicrobial action, is a carbonic anhydrase inhibitor. Two representative sulfonamide compounds, one with antidiabetic activity (Orinase) and the other, primarily a carbonic anhydrase (Diamox), are also shown. Unlike the typical carbonic anhydrase inhibitors, chlorothiazide and its derivatives act mainly to inhibit sodium chloride reabsorption. All these saliuretic sulfoncamides have in common a configuration in which the sulfamyl group and a halogen are in the ortho position. The thiazide grouping does not appear essential for diuretic activity because in chlorthalidone (Hygroton), it has been replaced by a pthalamidine group. In parentheses below ea,ch compound, a recommended single oral dosage and its reported duration of action are presented.
Therapeutic Application General Principles
The intelligent use of chlorothiazide and its derivatives in treatment of patients is wholly dependent on a thorough knowledge of the pharmacology of these compounds in relationship to Increased potassium excretion caused by chlorothiazide is viewed as a consequence of the activity of the drug in blocking sodium reabsorption proximal to the site of potassium secretion. According to this concept, all chlorothiazide-type compounds will cause potassium depletion in proportion to their capacity to block proximal sodium reabsorption by diverting more sodium distally to the site of potassium secretion.
Unlike mercurial agents, chlorothiazide either depresser or does not change excretion of free water during a water diuresis. These data suggest that chlorothiazide acts both in the proximal and distal portions of the nephron, while mercurial agents may act largely in the proximal tubule.
The different mode of action of chlorothiazide on tubular reabsorption of electrolytes, as compared with other diuretic agents (acetazoleamide, organomercurials, spirolactone), affords evidence that a number of discrete tubular transport mechanisms participate in the regulation of electrolyte and water bal-12"1 aniee anid provide a rational basis for combined use of various types of diuretic agents in treating edematous patients.
The nature of the antihypertensive action of chiorothiazide has not yet been elucidated. The effect may be related to electrolyte and fluid depletioni, but evidence for a more direct action on the circulation is reviewed.
Other aspects of the pharmacology of clilorothiazide and its derivatives are considered, and the application of this information in treatment of states of edema or hvpertension is discussed.
